United States Pharmaceuticals

Amgen Fremont Inc (ABGX)

Track

Ticker: ABGX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
RINGO WILLIAM R CEO and President Executive Director
Transaction date
Purchase
Price
82.02
Quantity 54,116 +16.4%
Value US$4,191,754
DAVIS C GEOFFREY Chief Scientific Officer Officer
Transaction date
Planned sale
Price
156.65
Quantity 93,602 +16.4%
Value US$1,538,097
DAVIS C GEOFFREY Chief Scientific Officer Officer
Transaction date
Sale
Price
85.69
Quantity 25,182 +9.9%
Value US$4,549,506
DAVIS C GEOFFREY Chief Scientific Officer Officer
Transaction date
Sale
Price
13.33
Quantity 13,748 -49.2%
Value US$183,233
DAVIS C GEOFFREY Chief Scientific Officer Officer
Transaction date
Sale
Price
13.33
Quantity 31,760 -69.1%
Value US$423,297
WIGGANS THOMAS G
Transaction date
Purchase
Price
15.21
Quantity 1,000 +inf%
Value US$15,205
DAVIS C GEOFFREY Chief Scientific Officer
Transaction date
Planned sale
Price
15.22
Quantity 4,064 -22.3%
Value US$61,854
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2005-03-02 2005-02-28 B Purchase RINGO WILLIAM R

CEO and President

Executive Director
54,116 +16.4%
82.02
US$4,191,754 		54,116 +16.4% 82.02 US$4,191,754
2005-01-03 2004-12-29 PlS Planned sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
93,602 +16.4%
156.65
US$1,538,097 		93,602 +16.4% 156.65 US$1,538,097
2004-08-30 2004-08-26 S Sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
25,182 +9.9%
85.69
US$4,549,506 		25,182 +9.9% 85.69 US$4,549,506
2004-04-16 2004-04-14 S Sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
13,748 -49.2%
13.33
US$183,233 		13,748 -49.2% 13.33 US$183,233
2004-04-16 2004-04-14 S Sale DAVIS C GEOFFREY

Chief Scientific Officer

Officer
31,760 -69.1%
13.33
US$423,297 		31,760 -69.1% 13.33 US$423,297
2004-02-09 2004-02-06 B Purchase WIGGANS THOMAS G
1,000 +inf%
15.21
US$15,205 		1,000 +inf% 15.21 US$15,205
2004-02-09 2004-02-06 PlS Planned sale DAVIS C GEOFFREY

Chief Scientific Officer
4,064 -22.3%
15.22
US$61,854 		4,064 -22.3% 15.22 US$61,854
Explore more

More insider trading research around Amgen Fremont Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America